Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

18.0K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncocytic Intraductal Carcinoma of the Parotid Gland with STRN::ALK Fusion.

Head and neck pathology·2026
Same author

Biallelic ARID1A Alterations: A Promising Novel Biomarker for Risk Stratification and Management in Pediatric Malignant Hepatocellular Tumors.

The American journal of surgical pathology·2026
Same author

Oncologic outcomes of parenchyma-sparing resection for hepatoblastoma.

Journal of pediatric surgery·2026
Same author

<i>NTRK</i> Gene Fusions: A Compendium of Fusion Partners and Tumor Types.

JCO precision oncology·2026
Same author

Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Global Re-Analysis Confirms Absence of the <i>DNAJB1</i>::<i>PRKACA</i> Fusion in Hepatoblastoma. Comment on Fleifil et al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. <i>Cancers</i> 2025, <i>17</i>, 83.

Cancers·2026
Same journal

Epigenetic CD4+ T-Cell Quantification from Dried Blood Spots Using a qPCR-Based Assay.

The Journal of molecular diagnostics : JMD·2026
Same journal

Segmental Copy Number Variant Detection Using an Amplicon-based NGS Panel for Integrated Glioma Classification.

The Journal of molecular diagnostics : JMD·2026
Same journal

Clinical Validation of the Roche cobas and cobas 4800 Human Papillomavirus Tests on Self-Collected Vaginal Dry Swabs versus Practitioner-Collected Cervical Specimens Using the VALHUDES Protocol.

The Journal of molecular diagnostics : JMD·2026
Same journal

Long-Read Nanopore Sequencing Enhances BRCA1/2 Variant Detection Compared with Ion Torrent Analysis.

The Journal of molecular diagnostics : JMD·2026
Same journal

Endonuclease-Assisted Selective Exponential Amplification for Ultrasensitive Enrichment and Detection of Low-Abundance Mutant Alleles in Lung Cancer.

The Journal of molecular diagnostics : JMD·2026
Same journal

Validation of NTRK Fusion Detection Using an Ultrarapid, Fully Automated Cartridge-Based PCR Assay.

The Journal of molecular diagnostics : JMD·2026
See all related articles

Related Experiment Video

Updated: Sep 25, 2025

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.5K

A Validation Framework for Somatic Copy Number Detection in Targeted Sequencing Panels.

Raghu Chandramohan1, Jacquelyn Reuther2, Ilavarasi Gandhi2

  • 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.

The Journal of Molecular Diagnostics : JMD
|April 29, 2022
PubMed
Summary
This summary is machine-generated.

This study presents a validated pipeline for detecting somatic copy number alterations (SCNAs) using targeted next-generation sequencing. The optimized method accurately identifies clinically significant CNVs in tumor samples, improving cancer diagnostics.

More Related Videos

Detection of Copy Number Alterations Using Single Cell Sequencing
09:45

Detection of Copy Number Alterations Using Single Cell Sequencing

Published on: February 17, 2017

11.8K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.9K

Related Experiment Videos

Last Updated: Sep 25, 2025

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.5K
Detection of Copy Number Alterations Using Single Cell Sequencing
09:45

Detection of Copy Number Alterations Using Single Cell Sequencing

Published on: February 17, 2017

11.8K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.9K

Area of Science:

  • Genomics
  • Cancer Genomics
  • Bioinformatics

Background:

  • Somatic copy number alterations (SCNAs) are crucial biomarkers in oncology.
  • Targeted next-generation sequencing (NGS) panels are increasingly used for SCNA detection.
  • Limited data exists on optimizing and validating SCNA detection pipelines for small targeted panels.

Purpose of the Study:

  • To describe the validation and implementation of a tumor-only SCNA detection pipeline.
  • To optimize the pipeline for clinical use by evaluating key parameters.
  • To assess the pipeline's performance in identifying clinically relevant copy number variations (CNVs).

Main Methods:

  • Utilized CNVkit with custom modules for SCNA calling.
  • Optimized parameters including reference normal establishment, sequencing coverage, tumor purity, sample quality, and bin size.
  • Validated the pipeline on reference materials and clinical tumor samples, including pediatric solid tumors.

Main Results:

  • Achieved 100% sensitivity and 93% specificity in an independent validation cohort.
  • Identified intragenic CNVs within tumor suppressor genes using custom modules.
  • Detected SCNAs in 86% of previously profiled pediatric tumors, with 46% showing potential clinical relevance.

Conclusions:

  • Rigorous validation is essential for establishing the performance characteristics of SCNA detection pipelines.
  • The presented framework enables optimal SCNA detection in targeted sequencing panels for clinical applications.
  • The validated pipeline can uncover clinically significant CNVs, aiding in cancer diagnosis and treatment decisions.